Dr Reddy’s Profit After Tax Rises 12% To Rs 1,113 Crore in Q2
Last Updated: October 28, 2022, 18:23 IST
Dr Reddy’s profit after tax had stood at Rs 992 crore in the July-September 2021 quarter.
Dr Reddy’s revenues rise 9 per cent y-o-y to Rs 6,305.70 crore in the second quarter of FY23
Dr Reddy’s Laboratories Ltd on Friday said its consolidated profit after tax (PAT) for the quarter ended September 30, 2022 was up by 12 per cent at Rs 1,112.80 crore as against Rs 992 crore in the same quarter a year ago. Revenues during the quarter under discussion were up by nine per cent y-o-y to Rs 6,305.70 crore in the second quarter of FY23.
Commenting on the results, its Co-Chairman and MD, G V Prasad said, “We are pleased with the strong financial performance in the current quarter, driven by the launch of Lenalidomide capsules in the US market. Our focus is to build a robust pipeline with products that improve affordability and access to patients globally. We continue to progress well in our productivity, innovation and sustainability agenda.”
Read all the Latest Business News here
